Actym Therapeutics has a total of 108 patents globally, out of which 27 have been granted. Of these 108 patents, more than 86% patents are active. United States of America is where Actym Therapeutics has filed the maximum number of patents, followed by Japan and Canada. Parallelly, USA seems to be the main focused R&D centre and also is the origin country of Actym Therapeutics.
Actym Therapeutics founded in 2017, Actym Therapeutics is a Berkeley-based biotechnology company developing targeted cancer therapies using its proprietary STACT™ platform. The platform uses engineered bacterial systems to deliver therapeutic agents directly to tumors, aiming to reduce side effects associated with conventional treatments. Its lead candidate, ACTM-838, is being evaluated in clinical trials for advanced solid tumors.
Do read about some of the most popular patents of Actym Therapeutics which have been covered by us in this article and also you can find Actym Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Actym Therapeutics patent portfolio.
How many patents does Actym Therapeutics have?
Actym Therapeutics has a total of 108 patents globally. These patents belong to 4 unique patent families. Out of 108 patents, 94 patents are active.
How Many Patents did Actym Therapeutics File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Actym Therapeutics Applications Filed | Actym Therapeutics Patents Granted |
| 2026 | 2 | 5 |
| 2025 | 5 | 12 |
| 2024 | 3 | 5 |
| 2023 | 6 | 2 |
| 2022 | 14 | 2 |
| 2021 | 21 | 1 |
| 2020 | 33 | – |
| 2019 | 19 | – |
| 2018 | 5 | – |
How many Actym Therapeutics patents are Alive/Dead?
Worldwide Patents

How Many Patents did Actym Therapeutics File in Different Countries?

Countries in which Actym Therapeutics Filed Patents
| Country | Patents |
| United States of America | 15 |
| Japan | 13 |
| Canada | 9 |
| Europe (EPO) | 8 |
| Hong Kong (S.A.R.) | 7 |
| New Zealand | 6 |
| Australia | 6 |
| China | 5 |
| Singapore | 5 |
| Korea (South) | 5 |
| Eurasia | 4 |
| Mexico | 4 |
| India | 4 |
| Israel | 4 |
| Brazil | 4 |
| Macao | 1 |
| Republic of Moldova | 1 |
Where are Research Centres of Actym Therapeutics Patents Located?
The Research Centre for all the Actym Therapeutics patents is the United States of America.
10 Best Actym Therapeutics Patents
WO2019014398A1 is the most popular patent in the Actym Therapeutics portfolio. It has received 44 citations.
Below is the list of 10 most cited patents of Actym Therapeutics:
| Publication Number | Citation Count |
| WO2019014398A1 | 44 |
| US11168326B2 | 18 |
| US20220119824A1 | 13 |
| US20220135980A1 | 6 |
| CN113748124A | 6 |
| US11779612B2 | 4 |
| EP3820992A2 | 4 |
| CA3069523A1 | 4 |
| US11242528B2 | 3 |
| US20220154136A1 | 3 |
What Percentage of Actym Therapeutics US Patent Applications were Granted?
Actym Therapeutics (Excluding its subsidiaries) has filed 14 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 5 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Actym Therapeutics patent prosecution at the USPTO.

Which Law Firms are managing US Patents for Actym Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Womble Bond Dickinson Seidman Group | 14 | 100.00% |
What are Actym Therapeutics key innovation segments?
What Technologies are Covered by Actym Therapeutics?

The chart below distributes patents filed by Actym Therapeutics